Delivery Order SPE2DB20D2104-SPE2DB25FMLZV
Award Date
3/26/25
Potential Completion Date
3/27/25
Potential Value
$14K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, involves the delivery of Ondansetron ODT 4 MG Tablets in 30-count packages. The $16,001.94 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA), a defense agency. The contract has an ultimate completion date of May 30, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award is for the delivery of Ondansetron ODT 4 mg tablets to the Defense Logistics Agency (DLA). The $1,940.22 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on March 6, 2025. The contract has a completion date of March 7, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is a $17,929.33 Firm Fixed Price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The award is for the delivery of Ondansetron ODT 4 mg tablets in 30-count packages. The contract has an ultimate completion date of May 27, 2025. Amerisourcebergen Drug Corp also holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide ondansetron ODT 4 mg tablets. The contract is a delivery order valued at $20,665.09 with a firm fixed price and an ultimate completion date of November 14, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as the primary vehicle for providing...
The Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Ondansetron ODT 4 mg tablets. The contract is valued at $8,139.82 and has a completion date of September 19, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,997.57 firm fixed-price delivery order is for the supply of 4,567,760 units of Ondansetron ODT 4 mg tablets. The contract has an ultimate completion date of April 2, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order contract valued at $18,768.35. The contract was awarded by the Defense Logistics Agency (DLA) for the supply of Ondansetron ODT 4 mg tablets. The contract has an ultimate completion date of November 7, 2024 and is a firm fixed-price contract. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides for the supply of Ondansetron ODT 4 MG tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The $6,281.99 firm fixed-price delivery order has a completion date of March 6, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award from the Defense Logistics Agency (DLA) was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Ondansetron ODT 8 mg tablets. The $11,254.23 fixed-price Delivery Order contract has a completion date of May 8, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Ondansetron ODT 8 mg tablets. The award, made by the Defense Logistics Agency (DLA), is a Delivery Order under an Indefinite Delivery Contract (IDC) with a ceiling value of $4,354.88 and a period of performance through November 1, 2024. The contract is for Firm Fixed Price with no set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 IDC with...